Aspiriant LLC’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-364
| Closed | -$231K | – | 314 |
|
|
2025
Q1 | $231K | Sell |
364
-23
| -6% | -$14.6K | 0.01% | 271 |
|
|
2024
Q4 | $276K | Buy |
387
+49
| +14% | +$34.9K | 0.01% | 241 |
|
|
2024
Q3 | $355K | Sell |
338
-14
| -4% | -$14.7K | 0.01% | 217 |
|
|
2024
Q2 | $370K | Sell |
352
-46
| -12% | -$48.3K | 0.02% | 209 |
|
|
2024
Q1 | $383K | Hold |
398
| – | – | 0.02% | 221 |
|
|
2023
Q4 | $350K | Buy |
398
+56
| +16% | +$49.2K | 0.02% | 224 |
|
|
2023
Q3 | $281K | Buy |
+342
| New | +$281K | 0.01% | 234 |
|